. 2015 Mar 22;2015:481972. doi: 10.1155/2015/481972

Table 3.

Comparisons of TLR2 and TLR4 mRNA expression levels according to cagA and vacA genotypes of H. pylori in infected patients before and after bacteria eradication treatment.

	TLR2			TLR4
	Samples (%)	RQ median (range)	P value	Samples (%)	RQ median (range)	P value
Before treatment
cagA+	11/23 (48.0)	1.32		11/23 (48.0)	1.75	0.689
cagA+	11/23 (48.0)	0.66–23.05	0.518	11/23 (48.0)	0.65–11.09
cagA−	12/23 (52.0)	1.41	0.518	12/23 (52.0)	1.80
cagA−	12/23 (52.0)	0.71–12.63		12/23 (52.0)	0.97–7.17
vacA s1m1	12/25 (48.0)	1.51		12/25 (48.0)	1.97	0.978
vacA s1m1	12/25 (48.0)	0.67–12.63	0.849	12/25 (48.0)	0.65–7.17
vacA others	13/25 (52.0)	1.31	0.849	13/25 (52.0)	2.02
vacA others	13/25 (52.0)	0.66–23.05		13/25 (52.0)	0.97–11.09
After treatment
Eradicated
cagA+	5/11 (46.0)	1.55		5/12 (42.0)	1.61	0.876
cagA+	5/11 (46.0)	0.50–7.21	0.662	5/12 (42.0)	1.06–12.01
cagA−	6/11 (54.0)	2.16	0.662	7/12 (58.0)	2.69
cagA−	6/11 (54.0)	0.59–43.12		7/12 (58.0)	0.64–28.07
vacA s1m1	7/13 (54.0)	0.71		7/13 (54.0)	1.42	0.234
vacA s1m1	7/13 (54.0)	0.34–7.21	0.234	7/13 (54.0)	0.64–12.01
vacA others	6/13 (46.0)	2.65	0.234	6/13 (46.0)	3.30
vacA others	6/13 (46.0)	0.59–43.12		6/13 (46.0)	0.89–28.07
Noneradicated
cagA+	6/12 (50.0)	1.87		6/10 (60.0)	1.99	0.762
cagA+	6/12 (50.0)	1.03–5.61	0.699	6/10 (60.0)	0.56–3.92
cagA−	6/12 (50.0)	1.34	0.699	4/10 (40.0)	2.59
cagA−	6/12 (50.0)	0.37–6.36		4/10 (40.0)	0.82–9.75
vacA s1m1	5/12 (42.0)	1.36		4/11 (36.4)	1.66	0.230
vacA s1m1	5/12 (42.0)	0.65–5.61	0.639	4/11 (36.4)	0.56–2.99
vacA others	7/12 (58.0)	1.92	0.639	7/11 (63.6)	3.52
vacA others	7/12 (58.0)	0.37–6.36		7/11 (63.6)	0.82–9.75

vacAothers (s1m2, s2m2, s1_, s2_, and _m1); P value = Mann-Whitney test; P < 0.05.